Tirzepatide can change hunger, weight, blood sugar, and pressure.
The studies show both benefit and harm. Tirzepatide first gained FDA approval for diabetes in 2022.
Tirzepatide can curb hunger before weight changes
Hunger may ease before your belt feels loose. Tirzepatide copies two hormones sent out by your bowel after a meal.
The shot contains 39 amino acids, which are the building blocks of protein. That count won't predict your experience.
Doctors call one of the copied hormones GLP-1. It helps your body handle insulin and hunger.
In May 2022, the FDA approved tirzepatide for type 2 diabetes. Long-term weight approval came in November 2023.
After food, both hormones tell the pancreas to send out insulin. They can also leave you feeling full.
Some older drugs copy just 1 hormone. Tirzepatide copies both, but that doesn't promise you a better result.
The largest study found about 21% average weight loss at the top dose over 72 weeks. Your loss could be smaller, larger, or none.
Nausea and other trouble can happen. The effects page lays out the details for you.
Our figures come from published studies. We don't sell tirzepatide or write prescriptions.
Tirzepatide lowered sugar, weight, and blood pressure
The first study was large, but it lasted less than a year. It followed 1,879 adults with type 2 diabetes.
Semaglutide copies 1 gut hormone, called GLP-1. At 5, 10, and 15 mg, tirzepatide lowered the three-month sugar test more than semaglutide [3].
Weight loss was also greater with tirzepatide than with semaglutide, the GLP-1 shot [3]. The extra loss at 5 mg was smaller than at the top amount.
The 72-week weight study followed 2,539 adults without diabetes. By week 72, the groups taking 5, 10, or 15 mg had lost far more than the sugar-pill group [4].
Semaglutide is the GLP-1 shot in the next direct test too. Tirzepatide led to more loss after 72 weeks [5].
The heart answer isn't settled. Across seven trials, the upper blood-pressure reading fell at 5 mg, 10 mg, and 15 mg [10].
Another review found helpful drops in the diabetes studies [8]. A later study found 16% fewer heart-and-kidney problems than with dulaglutide, another GLP-1 shot [13].
That type 2 diabetes study included adults who also had heart disease. It may not fit someone without both type 2 diabetes and heart disease.
One shot lasts a week because a fat-like part holds the drug to albumin, one of the proteins in your blood [1]. That hold lets tirzepatide leave slowly.
Dish tests used the paper names GIP and GLP-1 for the two gut hormones [2]. The tests found unequal strength, but cells can't predict what you'll notice.
Those letter names aren't a verdict about you. The useful facts are the changes in sugar, weight, and blood pressure.
The full Tirzepatide research page names each comparison drug. We won't promise a result or sell you tirzepatide.
Tirzepatide copies two hormones made by your gut
Two hormones leave your bowel after a meal. One is called GLP-1, and it helps the pancreas release insulin when needed.
Many older drugs copy only 1 hormone, GLP-1. Tirzepatide copies both hormones, so several parts of your body may respond.
When sugar runs high, your pancreas sends more insulin into your blood. Your liver gets a weaker order to add sugar.
Your stomach may hold food longer, which can extend fullness. Your brain may also get quieter hunger messages [1].
Direct tests moved blood sugar and weight farther than a medicine limited to just 1 hormone. Cell tests suggest the hormone called GIP may add to the GLP-1 effect [2].
GLP-1 can slow the stomach and curb hunger. It also aids sugar control after meals.
GIP is the second gut hormone, and it adds another way to control sugar. Neither hormone can forecast your response, so you won't know from its name.
That's the short answer. The full Tirzepatide research page separates results in people, mice, and cells.
Tirzepatide peptide stays long enough for weekly shots
“Tirzepatide peptide” means a short, man-made protein chain. That chain wouldn't survive your stomach, so this drug isn't a pill.
- Why it lasts: a fat-like part grips albumin, a blood protein that carries many things.
- Time in your body: about 5 days for half of the drug to leave.
- How you take it: the shot goes under your skin.
- What it copies: two hormones your bowel sends out after meals.
That slow clearing lets one shot work through the week [1][2]. The same timing supports weekly use for type 2 diabetes; GLP-1 is only a name, and you don't need it to follow the timing.
Tirzepatide results cover more than weight
These figures show what happened across groups; they aren't your forecast. Each note points to the paper behind it.
- Blood sugar in type 2 diabetes: over 40 weeks, tirzepatide lowered the three-month test farther; semaglutide had the smaller fall and copies GLP-1 [3].
- Weight without diabetes: people taking 5/10/15 mg lost much more over 72 weeks than people taking a sugar pill [4].
- Weight in study 5, the direct comparison: tirzepatide caused more loss at 72 weeks than semaglutide, another GLP-1 drug [5].
- Upper blood-pressure reading: the reading fell at 5/10/15 mg across 7 trials [10].
- Cholesterol and blood fat: harmful kinds fell, while the helpful kind rose [10].
- Heart and kidney problems: 1 later study found fewer combined problems than with dulaglutide, a GLP-1 drug [13]. That type 2 diabetes result still needs more study before it can guide care.
For weight alone, read tirzepatide weight loss. Don't miss the possible Tirzepatide effects.